Literature DB >> 6183128

Anti-nuclear matrix antibodies in mixed connective tissue disease.

M H Salden, C A Van Eekelen, W J Habets, G Vierwinden, L B Van de Putte, W J Van Venrooy.   

Abstract

Purified serum antibodies of patients suffering from mixed connective tissue disease were tested for their immunological specificity against nuclear constituents of HeLa S3 cells. In the indirect immunofluorescent staining technique, using cells and nuclei as targets, a typical speckled intranuclear staining pattern was obtained, that persisted after degradation and extraction of all nucleic acids and their associated proteins. This treatment of nuclei with detergents, DNase, RNase and high salt concentrations leave intact only the so-called nuclear matrix which is an intranuclear proteinaceous network. Further proof that nuclear matrix proteins were targets of the autoimmune reaction was obtained after separation of these proteins by sodium dodecyl sulfate polyacrylamide gel electrophoresis and electrophoretic transfer to nitrocellulose (blotting). A specific number of blot-transferred matrix proteins reacted with purified serum antibodies of 10 patients with mixed connective tissue disease, whereas this reaction was negative with normal healthy individuals. IgG preparations of 7 patients with systemic lupus erythematosus showed a weak, if any, reaction with matrix constituents. Obviously, in some connective tissue diseases serum antibodies are expressed which are directed to specific nuclear matrix antigens.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6183128     DOI: 10.1002/eji.1830120915

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  5 in total

1.  Association of La and Ro antigens with intracellular structures in HEp-2 carcinoma cells.

Authors:  M Bachmann; W J Mayet; H C Schröder; K Pfeifer; K H Meyer zum Büschenfelde; W E Müller
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

2.  Antibodies to soluble and insoluble nuclear antigens in systemic diseases.

Authors:  W J Van Venrooij; W J Habets; D J de Rooij; L B van de Putte
Journal:  Clin Rheumatol       Date:  1987-06       Impact factor: 2.980

3.  Quantitation of anti-RNP and anti-Sm antibodies in MCTD and SLE patients by immunoblotting.

Authors:  W J Habets; D J de Rooij; M H Hoet; L B van de Putte; W J van Venrooij
Journal:  Clin Exp Immunol       Date:  1985-02       Impact factor: 4.330

4.  Antibodies against distinct nuclear matrix proteins are characteristic for mixed connective tissue disease.

Authors:  W J Habets; D J de Rooij; M H Salden; A P Verhagen; C A van Eekelen; L B van de Putte; W J van Venrooij
Journal:  Clin Exp Immunol       Date:  1983-10       Impact factor: 4.330

5.  The RNA binding protein La influences both the accuracy and the efficiency of RNA polymerase III transcription in vitro.

Authors:  E Gottlieb; J A Steitz
Journal:  EMBO J       Date:  1989-03       Impact factor: 11.598

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.